An Official Website of the United States Government
Company Information:
Name:
VIDASYM, INC.
Address:
1673 CEDAR GLEN DR
LIBERTYVILLE, IL 60048-3924
LIBERTYVILLE, IL 60048-3924
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
New drug Vida-5 for treating chronic kidney disease progression
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jinshyun R. Wu-wong – 847-863-9818
Award Amount:
$219,123.00
Abstract:
DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Anemia, cardiovascular diseases, secondary hyperparathyroidism, renal osteodystrophy and other complications are common in CKD. Current treatmentsincluding ACE inhibitors for CKD patients… More
Novel drug VS-105 for treatment of diabetic nephropathy
Award Year / Program / Phase:
2012 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF CHICAGO
Abstract:
DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Diabetes is by far the leading cause of CKD (diabetic nephropathy), accounting for 44% of new cases of dialysis (in 2005). Current treatments including ACE inhibitors for CKD patients mainly… More
New drug VS-501 for treating hyperphosphatemia in chronic kidney disease
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jinshyun R. Wu-wong – 847-260-8432
Award Amount:
$217,354.00
Abstract:
DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Despite the various treatments available to CKD patients, the five-year survival rate is ~33%. Inadequately controlled serum phosphate levels in CKD can lead to various pathologies of… More